A spokesperson for Novo Nordisk told MailOnline: 'We continuously collect and analyse data on the use of our medicines post marketing authorisation, and follow international pharmacovigilance standards to report and analyse any adverse events experienced by people taking our medicines.' They added: 'We work closely with the Medicines and Healthcare products Regulatory Agency (MHRA) to ensure that healthcare professionals have a thorough and full understanding of the safety profile of our medicines.' Meanwhile the MHRA, which polices the safety of drugs used in the UK, said: 'As with all medicines, the safety of Wegovy is kept under continual review to ensure the benefits outweigh the risks
Los autores de un metaanlisis de 2013 combinaron los resultados de este estudio con los de 12 estudios ms pequeos [49]
No solo es til contra la diabetes de tipo II, sino que tambin reduce el riesgo de infarto en un 20% [Esta pieza es una versin de uno de los envos de la newsletter semanal de Tendencias de EL PAS, que sale todos los martes
AILSA CHANG, HOST: Time is running out for people who rely on cheaper alternatives for a name-brand obesity drug
Sulfonylurea plus Ozempic: monitor for low blood sugar
Chemical shifts are quoted in parts per million (ppm) and were referenced to the residual solvent peak